Age as a prognostic factor in small cell lung cancer (SCLC): randomized trial of high dose epirubicin ¿cisplatin (HDEP) versus etoposide ¿cisplatin (EP) in SCLC. A retrospective analysis 2001 Academic Article uri icon

authors

  • Camps C.
  • Meana A.
  • Lomas M.
  • Vadell C.
  • Alonso C.
  • Campbell J.
  • Rosell R.
  • Artal A.
  • Gómez-Codina J.
  • González-Larriba J.L.
  • Barneto I.
  • CARRATO MENA, ALFREDO
  • Isla D.
  • García-Girón C.
  • Font A.

publication date

  • 2001